CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells

Margaret Gil, Marcin P. Komorowski, Mukund Seshadri, Hanna Rokita, A. J.Robert McGray, Mateusz Opyrchal, Kunle O. Odunsi, Danuta Kozbor

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells'. Together they form a unique fingerprint.

Medicine & Life Sciences